Company intelligence / Profile preview

Menning Labs

Los Angeles, California, United Statessri.com ↗

Ownership: Private
Employees: ~5
Development stage: Commercial

Overview

Menning Labs develops and manufactures topical skincare products, including an acne product line. Their offerings are evaluated in consumer studies for efficacy. The company leverages a patent-pending XDF™ delivery system to enhance the bioavailability of plant-based actives in their formulations. Clinical results cited by partners include improvements in facial acne, reduced inflammation/redness, improved tone/texture, and balanced skin microbiome.

Therapeutic areas: Dermatology
Industry: Non-Drug Biotech

Drug pipeline

1 asset

EQ Clear Skin Collection

Commercial

Indications: Acne

Partnerships

Citruslabs

Beyond the preview

Go deeper on Menning Labs.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Menning Labs.

Explore the full profile